vs
Side-by-side financial comparison of JBG SMITH Properties (JBGS) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
JBG SMITH Properties is the larger business by last-quarter revenue ($127.6M vs $83.1M, roughly 1.5× PROCEPT BioRobotics Corp). JBG SMITH Properties runs the higher net margin — -35.7% vs -38.1%, a 2.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -2.5%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -6.3%).
JBG SMITH PropertiesJBGSEarnings & Financial Report
JBG SMITH Properties is a publicly traded real estate investment trust based in Bethesda, Maryland.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
JBGS vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $127.6M | $83.1M |
| Net Profit | $-45.5M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | -47.5% | -4.1% |
| Net Margin | -35.7% | -38.1% |
| Revenue YoY | -2.5% | 20.2% |
| Net Profit YoY | 24.0% | -27.9% |
| EPS (diluted) | $-0.76 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $127.6M | $76.4M | ||
| Q3 25 | $123.9M | $83.3M | ||
| Q2 25 | $126.5M | $79.2M | ||
| Q1 25 | $120.7M | $69.2M | ||
| Q4 24 | $130.8M | $68.2M | ||
| Q3 24 | $136.0M | $58.4M | ||
| Q2 24 | $135.3M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-45.5M | $-29.8M | ||
| Q3 25 | $-28.6M | $-21.4M | ||
| Q2 25 | $-19.2M | $-19.6M | ||
| Q1 25 | $-45.7M | $-24.7M | ||
| Q4 24 | $-59.9M | $-18.9M | ||
| Q3 24 | $-27.0M | $-21.0M | ||
| Q2 24 | $-24.4M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | -47.5% | -40.6% | ||
| Q3 25 | -27.5% | -27.8% | ||
| Q2 25 | -18.4% | -28.0% | ||
| Q1 25 | -44.7% | -39.7% | ||
| Q4 24 | -53.6% | -28.9% | ||
| Q3 24 | -22.4% | -38.4% | ||
| Q2 24 | -24.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -35.7% | -39.1% | ||
| Q3 25 | -23.1% | -25.7% | ||
| Q2 25 | -15.2% | -24.7% | ||
| Q1 25 | -37.9% | -35.8% | ||
| Q4 24 | -45.8% | -27.6% | ||
| Q3 24 | -19.8% | -35.9% | ||
| Q2 24 | -18.0% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.76 | $-0.54 | ||
| Q3 25 | $-0.48 | $-0.38 | ||
| Q2 25 | $-0.29 | $-0.35 | ||
| Q1 25 | $-0.56 | $-0.45 | ||
| Q4 24 | $-0.70 | $-0.34 | ||
| Q3 24 | $-0.32 | $-0.40 | ||
| Q2 24 | $-0.27 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $75.3M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $1.2B | $347.7M |
| Total Assets | $4.4B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $75.3M | $286.5M | ||
| Q3 25 | $64.4M | $294.3M | ||
| Q2 25 | $61.4M | $302.7M | ||
| Q1 25 | $81.3M | $316.2M | ||
| Q4 24 | $145.8M | $333.7M | ||
| Q3 24 | $137.0M | $196.8M | ||
| Q2 24 | $163.5M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $1.2B | $365.9M | ||
| Q3 25 | $1.2B | $380.3M | ||
| Q2 25 | $1.3B | $385.8M | ||
| Q1 25 | $1.6B | $389.2M | ||
| Q4 24 | $1.8B | $402.2M | ||
| Q3 24 | $1.9B | $241.2M | ||
| Q2 24 | $2.0B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $4.4B | $508.1M | ||
| Q3 25 | $4.4B | $511.5M | ||
| Q2 25 | $4.5B | $513.1M | ||
| Q1 25 | $4.7B | $519.4M | ||
| Q4 24 | $5.0B | $534.0M | ||
| Q3 24 | $5.2B | $374.1M | ||
| Q2 24 | $5.3B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.3M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $73.3M | $-10.3M | ||
| Q3 25 | $8.9M | $-6.6M | ||
| Q2 25 | $18.8M | $-15.0M | ||
| Q1 25 | $12.9M | $-17.0M | ||
| Q4 24 | $129.4M | $-32.4M | ||
| Q3 24 | $26.4M | $-18.8M | ||
| Q2 24 | $23.8M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
JBGS
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
